According to Maravai LifeSciences 's latest financial reports the company's current revenue (TTM) is $0.28 B. In 2022 the company made a revenue of $0.88 B an increase over the years 2021 revenue that were of $0.79 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.28 B | -67.28% |
2022 | $0.88 B | 10.48% |
2021 | $0.79 B | 181.33% |
2020 | $0.28 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Organovo ONVO | $0.24 M | -99.92% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $21.83 M | -92.44% | ๐ฌ๐ง UK |
Novavax NVAX | $0.69 B | 140.00% | ๐บ๐ธ USA |
Novocure
NVCR | $0.50 B | 76.28% | Jersey |